LCM
AZN icon

Logan Capital Management’s AstraZeneca AZN Stock Holding History

Logan Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,066
Closed -$5.53M – 295
2025
Q4 		$5.53M Buy
30,066
+4,774
+19% +$837K 0.23% 109
2025
Q3 		$3.88M Buy
25,292
+25,284
+316,050% +$3.83M 0.16% 132
2025
Q2 		$1.12K Hold
8
– – ﹤0.01% 419
2025
Q1 		$1.18K Hold
8
– – ﹤0.01% 503
2024
Q4 		$1.05K Buy
+8
New +$1.12K ﹤0.01% 484
2023
Q3 		– Sell
-8
Closed -$1.07K – 488
2023
Q2 		$1.07K Sell
8
-18,866
-100% -$2.78M ﹤0.01% 467
2023
Q1 		$2.62M Buy
18,874
+116
+0.6% +$15.6K 0.13% 156
2022
Q4 		$2.54M Buy
18,758
+719
+4% +$90.2K 0.13% 154
2022
Q3 		$1.98M Sell
18,039
-2,122
-11% -$269K 0.12% 156
2022
Q2 		$2.66M Buy
20,161
+2,578
+15% +$338K 0.15% 139
2022
Q1 		$2.33M Buy
17,583
+2,535
+17% +$304K 0.11% 157
2021
Q4 		$1.75M Buy
15,048
+1,004
+7% +$118K 0.08% 182
2021
Q3 		$1.69M Buy
14,044
+162
+1% +$18.9K 0.08% 182
2021
Q2 		$1.66M Buy
13,882
+1,573
+13% +$173K 0.08% 179
2021
Q1 		$1.23M Buy
12,309
+223
+2% +$22.4K 0.06% 198
2020
Q4 		$1.21M Sell
12,086
-220
-2% -$23.3K 0.06% 203
2020
Q3 		$1.35M Buy
12,306
+735
+6% +$81.7K 0.07% 221
2020
Q2 		$1.22M Buy
11,571
+425
+4% +$43.9K 0.07% 172
2020
Q1 		$996K Sell
11,146
-1,500
-12% -$141K 0.07% 203
2019
Q4 		$1.26M Buy
12,646
+168
+1% +$15.8K 0.07% 185
2019
Q3 		$1.11M Sell
12,478
-578
-4% -$50.1K 0.07% 193
2019
Q2 		$1.08M Buy
13,056
+579
+5% +$45.4K 0.06% 185
2019
Q1 		$1.01M Sell
12,477
-1,072
-8% -$84.5K 0.06% 190
2018
Q4 		$1.03M Buy
13,549
+1,048
+8% +$81.8K 0.08% 160
2018
Q3 		$990K Sell
12,501
-336
-3% -$25.4K 0.06% 184
2018
Q2 		$901K Buy
12,837
+464
+4% +$33.4K 0.06% 191
2018
Q1 		$866K Sell
12,373
-647
-5% -$44.8K 0.06% 189
2017
Q4 		$904K Buy
13,020
+855
+7% +$57.7K 0.06% 180
2017
Q3 		$824K Buy
12,165
+1,001
+9% +$63.2K 0.06% 191
2017
Q2 		$761K Buy
11,164
+189
+2% +$12.3K 0.06% 188
2017
Q1 		$684K Sell
10,975
-1,290
-11% -$75.1K 0.05% 197
2016
Q4 		$670K Sell
12,265
-43
-0.3% -$2.44K 0.05% 204
2016
Q3 		$809K Buy
12,308
+273
+2% +$17.8K 0.07% 181
2016
Q2 		$726K Buy
12,035
+2,186
+22% +$127K 0.06% 183
2016
Q1 		$554K Buy
9,849
+54
+0.6% +$3.25K 0.04% 232
2015
Q4 		$665K Buy
9,795
+97
+1% +$6.36K 0.05% 204
2015
Q3 		$617K Sell
9,698
-247
-2% -$16.3K 0.05% 211
2015
Q2 		$634K Buy
+9,945
New +$681K 0.05% 223

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Logan Capital Management's AZN Position: Q1 2026 in Review

Logan Capital Management sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 30,066 shares — an estimated $5.53M sold.

Logan Capital Management first reported a position in AZN in Q2 2015 and held it in 38 quarters. The position peaked at $5.53M in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Logan Capital Management reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Logan Capital Management sold 30,066 AstraZeneca shares in Q1 2026, an estimated $5.53M.
  • Logan Capital Management first reported a position in AstraZeneca in Q2 2015 and held it in 38 quarters.
  • Logan Capital Management's AstraZeneca position peaked at $5.53M in Q4 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.